157567-63-0 Usage
Uses
Used in Pharmaceutical Research and Development:
L-Leucine, N-methyl, (1R)-2-oxo-2-(phenylmethoxy)-1-(phenylmethyl)ethyl ester serves as a valuable building block for the synthesis of peptides and proteins. Its unique structure allows it to be a key component in the design and creation of novel bioactive molecules, potentially leading to the development of new drugs and therapies.
Used in Peptide and Protein Synthesis:
In the field of biochemistry, L-Leucine, N-methyl-,
(1R)-2-oxo-2-(phenylmethoxy)-1-(phenylmethyl)ethyl ester is utilized for its potential to enhance the synthesis of peptides and proteins. Its incorporation into these biological macromolecules can impart new properties or functions, which is crucial for understanding their mechanisms and for developing new therapeutic agents.
Used in Drug Development:
Due to its distinctive molecular structure, L-Leucine, N-methyl, (1R)-2-oxo-2-(phenylmethoxy)-1-(phenylmethyl)ethyl ester may have applications in the development of innovative drugs. Its ability to be integrated into complex molecular frameworks makes it a candidate for targeted drug design, potentially leading to more effective treatments with fewer side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 157567-63-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,7,5,6 and 7 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 157567-63:
(8*1)+(7*5)+(6*7)+(5*5)+(4*6)+(3*7)+(2*6)+(1*3)=170
170 % 10 = 0
So 157567-63-0 is a valid CAS Registry Number.
157567-63-0Relevant articles and documents
Total Synthesis of the Anthelmintic Cyclodepsipeptide, PF1022A
Ohyama, Makoto,Iinuma, Katsuharu,Isogai, Akira,Suzuki, Akinori
, p. 1193 - 1194 (2007/10/02)
The anthelmintic cyclooctadepsipeptide PF1022A and its antipode were synthesized starting from L-Nα-Boc-leucine (for PF1022A), D-N4a-Boc-leucine (for the antipode), L-lactic acid, and L-phenyllactic acid using Mitsunobu reaction and/